T. Rowe Price Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.68M Buy
44,064
+1,625
+4% +$172K ﹤0.01% 1291
2025
Q1
$5.27M Buy
42,439
+4,255
+11% +$528K ﹤0.01% 1245
2024
Q4
$4.7M Buy
38,184
+1,041
+3% +$128K ﹤0.01% 1301
2024
Q3
$4.14M Buy
37,143
+3,003
+9% +$335K ﹤0.01% 1355
2024
Q2
$3.64M Buy
34,140
+1,317
+4% +$141K ﹤0.01% 1324
2024
Q1
$3.95M Sell
32,823
-15,521
-32% -$1.87M ﹤0.01% 1290
2023
Q4
$5.95M Buy
48,344
+18,796
+64% +$2.31M ﹤0.01% 1172
2023
Q3
$3.83M Sell
29,548
-681
-2% -$88.2K ﹤0.01% 1242
2023
Q2
$3.75M Sell
30,229
-253
-0.8% -$31.4K ﹤0.01% 1259
2023
Q1
$4.46M Sell
30,482
-2,481
-8% -$363K ﹤0.01% 1211
2022
Q4
$5.25M Buy
32,963
+911
+3% +$145K ﹤0.01% 1179
2022
Q3
$4.27M Buy
32,052
+5,336
+20% +$711K ﹤0.01% 1233
2022
Q2
$4.17M Buy
26,716
+350
+1% +$54.6K ﹤0.01% 1444
2022
Q1
$4.1M Buy
26,366
+2,563
+11% +$399K ﹤0.01% 1490
2021
Q4
$3.03M Sell
23,803
-4,732
-17% -$603K ﹤0.01% 1580
2021
Q3
$3.72M Buy
28,535
+220
+0.8% +$28.7K ﹤0.01% 1551
2021
Q2
$5.03M Buy
28,315
+3,412
+14% +$606K ﹤0.01% 1500
2021
Q1
$4.09M Sell
24,903
-380,467
-94% -$62.5M ﹤0.01% 1511
2020
Q4
$66.9M Sell
405,370
-149,088
-27% -$24.6M 0.01% 853
2020
Q3
$79.1M Sell
554,458
-181,895
-25% -$25.9M 0.01% 724
2020
Q2
$81.2M Buy
736,353
+10,822
+1% +$1.19M 0.01% 696
2020
Q1
$72.4M Buy
725,531
+504,217
+228% +$50.3M 0.01% 667
2019
Q4
$33M Buy
221,314
+2,915
+1% +$435K ﹤0.01% 1039
2019
Q3
$28M Buy
218,399
+7,087
+3% +$908K ﹤0.01% 1046
2019
Q2
$30.1M Sell
211,312
-1,991
-0.9% -$284K ﹤0.01% 1045
2019
Q1
$30.5M Buy
213,303
+11,741
+6% +$1.68M ﹤0.01% 1039
2018
Q4
$25M Buy
201,562
+4,338
+2% +$538K ﹤0.01% 1075
2018
Q3
$33.2M Sell
197,224
-227,469
-54% -$38.2M ﹤0.01% 1057
2018
Q2
$73.2M Buy
424,693
+37,431
+10% +$6.45M 0.01% 754
2018
Q1
$58.5M Buy
387,262
+225,751
+140% +$34.1M 0.01% 814
2017
Q4
$21.7M Buy
161,511
+2,094
+1% +$282K ﹤0.01% 1150
2017
Q3
$23.3M Sell
159,417
-34,616
-18% -$5.06M ﹤0.01% 1120
2017
Q2
$30.2M Buy
194,033
+59,073
+44% +$9.19M 0.01% 1018
2017
Q1
$19.6M Buy
134,960
+19,980
+17% +$2.9M ﹤0.01% 1172
2016
Q4
$12.5M Buy
114,980
+6,750
+6% +$736K ﹤0.01% 1266
2016
Q3
$13.1M Buy
108,230
+3,130
+3% +$380K ﹤0.01% 1256
2016
Q2
$14.9M Sell
105,100
-2,607
-2% -$368K ﹤0.01% 1188
2016
Q1
$14.1M Sell
107,707
-270,857
-72% -$35.4M ﹤0.01% 1185
2015
Q4
$53.2M Sell
378,564
-9,673
-2% -$1.36M 0.01% 744
2015
Q3
$51.6M Sell
388,237
-5,563
-1% -$739K 0.01% 761
2015
Q2
$69.3M Buy
393,800
+100
+0% +$17.6K 0.01% 725
2015
Q1
$68M Sell
393,700
-1,400
-0.4% -$242K 0.01% 735
2014
Q4
$64.7M Sell
395,100
-6,700
-2% -$1.1M 0.01% 749
2014
Q3
$64.5M Sell
401,800
-88,400
-18% -$14.2M 0.01% 745
2014
Q2
$72.1M Sell
490,200
-439,150
-47% -$64.6M 0.02% 735
2014
Q1
$129M Sell
929,350
-65,150
-7% -$9.03M 0.03% 561
2013
Q4
$126M Sell
994,500
-4,200
-0.4% -$532K 0.03% 547
2013
Q3
$91.9M Buy
998,700
+10,500
+1% +$966K 0.02% 613
2013
Q2
$67.9M Buy
+988,200
New +$67.9M 0.02% 690